Overview

A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, multicenter, placebo controlled 5 parallel groups, confirmatory trial to evaluated the efficacy and safety of levetiracetam used as adjunctive treatment in patients from 16 to 65 years with epilepsy suffering from partial onset seizures.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Japan Co. Ltd.
Treatments:
Etiracetam
Levetiracetam
Piracetam